drugset / Trial / NCT01290965
Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will examine the effectiveness of 15 days of therapy with SCY-635 in reducing hepatitis C virus (HCV) RNA levels.
Timeline
- Start
- 2007-04
- Primary completion
- 2008-12
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | SCY-635 | Protein / enzyme biologic | 30 mg | Oral |
| Comparator | SCY-635 | Protein / enzyme biologic | 100 mg | Oral |
| Comparator | SCY-635 | Protein / enzyme biologic | 200 mg | Oral |
| Comparator | SCY-635 | Protein / enzyme biologic | 300 mg | Oral |